Debevoise Advises Precision Medicine Group in New $275 Million Investment
Debevoise & Plimpton LLP successfully advised Precision Medicine Group on a new $275 million investment, led by Berkshire Partners and TPG Growth, alongside a significant participation from Precision’s co-founders and management team and original investors Oak Investment Partners and J.H. Whitney.